Earnings ·
Globus Medical reported second quarter 2026 financial results on August 6, 2026
GMEDGlobus Medical Inc
Globus Medical reported second quarter 2026 financial results on August 6, 2026. Worldwide net sales increased 5.9% to $789.6 million, driven by a 14% rise in International Spine and 7% growth in US Spine. GAAP diluted EPS was $1.10, down 26.2% from the prior year due to a $110.5 million bargain purchase gain recognized in 2025 related to the Nevro acquisition. Non-GAAP diluted EPS rose 55.8% to $1.34. The company reaffirmed full-year 2026 revenue guidance of $3.18 billion to $3.22 billion and raised non-GAAP fully diluted EPS guidance to a range of $4.95 to $5.05 from the previous $4.70 to $4.80. Globus Medical is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs in spine, orthopedic trauma, joint reconstruction, and biomaterials.